Tiny is huge here.
Strange things happen at the molecular level. The Research Triangle Region's nanotechnology cluster exploits this phenomenon, manipulating very small materials - 1/100,000th the width of a human hair - on the atomic and molecular scale to create new materials and devices with applications in medicine, electronics, biomaterials and even energy production.
One of the top four nanotechnology regions in the country, the Research Triangle Region is home to more than 50 companies that are developing and producing nanomaterials, systems and processes that treat and cure disease, conserve the world's resources, reduce pollution and enhance quality of life.
Two dozen research centers support those innovations with research, development and education programs focused on applying this cross-cutting technology broadly.
North Carolina Center of Innovation for Nanobiotechnology (COIN) is a nonprofit, virtual center of innovation for nanobiotechnology and nanomedicine based in North Carolina. COIN supports those organizations that are most-impacted by the convergence of nano (advanced materials) and bio (life sciences) by ensuring that they have immediate structured access to all relevant resources and a conduit to key regulatory agencies impacting the field. COIN is a premier source of networking opportunities, information, and tailored innovation services that address client needs and catalyze and advance commercialization of nanobiotechnology.
The Triangle National Lithography Center, for instance, is the only public user laboratory in the nation with a 193-nanometer scanner lithography tool. This premier instrument for research and development can create microelectronic circuits and optical devices on the nanoscale level.
N.C. State-spinoff LaamScience Inc. is combining university-licensed technologies in nanoscience and nonwoven textiles to create hospital masks, furniture, wall coverings and airplane filters that neutralize viruses.
Nextreme Thermal Solutions makes industry-leading micro-thin films for embedding in electronic devices to keep components cool and operating.
And Asklepios BioPharmaceutical Inc. is using UNC-licensed technology to develop nanoparticles that deliver gene therapies directly to cells in the body to treat or cure hemophilia, muscular dystrophy and Lou Gehrig's Disease. In their product pipeline now are reagent products including Synthetically Designed Biological Nano Particles (BNP), with multi-tissue compatibility.
This cluster has massive presence in the region, and even larger promise to change medicine and industry worldwide. Fittingly, this is just a small sampling. Maybe not nanoparticle tiny, but still.